Amia Capital LLP Agios Pharmaceuticals, Inc. Transaction History

Amia Capital LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$33.21 - $46.54 $721,985 - $1.01 Million	-21,740 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $12,057 - $19,911	-356 Reduced 1.61%	21,740 $761,000
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $408,645 - $634,379	-11,862 Reduced 34.93%	22,096 $1.18 Million
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $167,434 - $285,838	-5,312 Reduced 13.53%	33,958 $1.21 Million
Q4 2019 Feb 13, 2020	BUY	$30.08 - $50.59 $1.18 Million - $1.99 Million	39,270 New	39,270 $1.88 Million

210

59.7M

365K

457K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.56B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.